The World Health Organization classification of lymphomas

Croatian Medical Journal

Volumn 43, Issue 5, 2002, Pages 527-534

  Jaki Razumovi, Jasminká ^a   Aurer, Igor ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Classification; Immunohistochemistry; Lymphoma; Molecular biology; World Health Organization

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CROATIA; EUROPE; HUMAN; LYMPHOMA; MEDICAL SOCIETY; NONHODGKIN LYMPHOMA; REPRODUCIBILITY; UNITED STATES; UNIVERSITY HOSPITAL; VALIDATION PROCESS; WORLD HEALTH ORGANIZATION;

HUMANS; LYMPHOMA; LYMPHOMA, B-CELL; LYMPHOMA, FOLLICULAR; LYMPHOMA, NON-HODGKIN; WORLD HEALTH ORGANIZATION;

EID: 0036811599     PISSN: 03539504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835-49.
2. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November 1997. Mod Pathol 2000;13:193-207.
3. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Ann Oncol 1999;10:1419-32.
4. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November 1997. Histopathology 2000;36:69-86.
5. Jaffe ES, Harris NL, Diebold J, Muller-Hermelink HK. World Health Organization Classification of lymphomas: A work in progress. Ann Oncol 1998;9 Suppl 5:S25-30.
6. Jaffe ES, Harris NL, Diebold J, Muller-Hermelink HK. World Health Organization Classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report. Am J Clin Pathol 1999;111:(1 Suppl 1)S8-12.
7. Mann RB, Berard CW. Criteria for the cytologic subclassification of follicular lymphomas: A proposed alternative method. Hematol Oncol 1983;1:187-92.
8. Fisher RI, Dahlberg S, Nathwani BN, Banks PM, Miller TP, Grogan TM. A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associted lymphoid tissue and monocytoid B-cell subcategories): A Southwest Oncology Group study. Blood 1995;85:1075-82.
9. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1998;16: 2780-95.
10. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, et al. EORTC classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997;90: 345-71.
11. Russell-Jones R. Primary cutaneous B-cell lymphoma: How useful is the new European Organization for Research and Treatment of Cancer (EORTC) classification? Br J Dermatol 1998;139:945-9.
12. Chan JK. The new World Health Organization classification of lymphomas: The past, the present, and the future. Hematol Oncol 2001;19:129-50.
13. Sander CA, Kind P, Kaudewitz P, Raffeld M, Jaffe E. The Revised European-American Classification of Lymphoid Neoplasms (REAL): A new perspective for the classification of cutaneous lymphomas. J Cutan Pathol 1997;24:329-41.
14. Hyjek E, Isaacson P. Primary B-cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. Hum Pathol 1988;19:1315-26.
15. Li G, Hansmann M, Zwingers T, Lennert K. Primary lymphomas of the lung: Morphological, immunohistochemical and clinical features. Histopathology 1990;16:519-31.
16. Mattia A, Ferry J, Harris N. Breast lymphoma. A B-cell spectrum including the low grade B-cell lymphoma of mucosa associated lymphoid tissue. Am J Surg Pathol 1993;17:574-87.
17. Wright DH, Jones DB, Clark H, Mead GM, Hodges E, Howell WM. Is adult-onset celiac disease due to a low-grade lymphoma of intraepithelial T lymphocytes? Lancet 1991;337:1373-4.
18. Kluin PM, Feller A, Gaulard P, Jaffe ES, Meijer CJ, Muller-Hermelink HK, et al. Peripheral T/NK-cell lymphoma: A report of the IXth Workshop of the European Association for Haematopathology. Histopathology 2001;38:250-70.
19. Kummer JA, Vermeer MH, Dukers D, Meijer CJ, Willemze R. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype. J Invest Dermatol 1997;109:636-40.
20. Chan JK, Banks PM, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, et al. A proposal for classification of lymphoid neoplasms (by the International Lymphoma Study Group). Histopathology 1994;25:517-36.
21. Nathwani BN, Anderson JR, Armitage JO, Cavalli F, Diebold J, Drachenberg MR, et al. Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project. J Clini Oncol 1999;17:2486-92.
22. Berger F, Felman P, Thieblemont C, Pradier T, Baseggio L, Bryon PA, et al. Non-MALT marginal zone B-cell lymphomas: A description of clinical presentation and outcome in 124 patients. Blood 2000;95:1950-6.
23. Yatabe Y, Suzuki R, Tobinai K, Matsuno Y, Ichinohasama R, Okamoto M, et al. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: A clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. Blood 2000;95:2253-61.
24. Horning SJ. Natural history of and therapy for the indolent non-Hodgkin's lymphomas. Semin Oncol 1993;20(5 Suppl 5):75-88.
25. de Bruin PC, Beljaards RC, van Heerde P, Van Der Valk P, Noorduyn LA, Van Krieken JH, et al. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype. Histopathology 1993;23:127-35.
26. Skinnider BF, Connors JM, Sutcliffe SB, Gascoyne RD. Anaplastic large cell lymphoma: A clinicopathologic analysis. Hematol Oncol 1999;17:137-48.
27. Falini B, Pileri S, Zinzani PL, Carbone A, Zagonel V, Wolf-Peeters C, et al. ALK+ lymphoma: Clinicopathological findings and outcome. Blood 1999;93:2697-706.
28. Gascoyne RD, Aoun P, Wu D, Chhanabhai M, Skinnider BF, Greiner TC, et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 1999;93:3913-21.
29. Shiota M, Mori S. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: A distinct clinicopathologic entity. Leukemia 1997;11 Suppl 3:538-40.
30. Falini B, Pulford K, Pucciarini A, Carbone A, De Wolf-Peeters C, Cordell J, et al. Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood 1999;94:3509-15.
31. Kuppers R, Klein U, Hansmann ML, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med 1999;341:1520-9.
32. Stewart DJ. Making and using DNA Microarrays: A short course at Cold Spring Harbor Laboratory. Genome Res 2000;10:1-3.
33. Friend SH. How microarrays and expression profiling will affect clinical practice. BMJ 1999;319:1306-7.
34. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-11.